Genotype | p -value 1 | Hazard ratio (95% CI) 2 | ||
---|---|---|---|---|
Control | Trial | |||
A | C155-Gal4/+;UAS-HTor1AΔE/+ | C155-Gal4/+; UAS-HSC3-RNAi/UAS-HTor1AΔE | <0.001 | 6.579 (4.726, 9.159) |
C155-Gal4/+;UAS-HSC3-RNAi/+ | <0.001 | 8.135 (5.87, 11.27) | ||
B | C155-Gal4/+;UAS-HTor1AΔE/+ | C155-Gal4/+;UAS-HTor1AΔΕ/UAS-Xbp1-RNAi | <0.001 | 6.796 (4.865, 9.492) |
C155-Gal4/+;UAS-HTor1AΔΕ/xbp1K13803 | <0.001 | 21.23 (13.19, 34.17) | ||
C155-Gal4/+; UAS-Xbp1-RNAi | C155-Gal4/+;UAS-HTor1AΔΕ/UAS-Xbp1-RNAi | <0.001 | 5.871 (4,351, 7.924) | |
C155-Gal4/+; xbp1K13803/+ | C155-Gal4/+;UAS-HTor1AΔΕ/xbp1K13803 | <0.001 | 15.42 (10.38, 22.9) | |
C | C155-Gal4/+;UAS-HTor1AΔE/+ | C155-Gal4/+;UAS-HTor1AΔE/UAS-ATF6-RNAi | <0.001 | 2.222 (1.672, 2.954) |
C155-Gal4/+;UAS-ATF6-RNAi/+ | <0.001 | 1.976 (1.562, 2.499) | ||
D | C155-Gal4/+;UAS-HTor1AΔE/+ | C155-Gal4/+;UAS-HTor1AΔE/UAS-Pek-RNAi | <0.001 | 2.914 (2.158, 3.934) |
C155-Gal4/+;UAS-Pek-RNAi/+ | <0.001 | 7.408 (5.368, 10.22) |